15.  SEGMENT REPORTING

 

As the Company operates as one reportable segment, all financial information required by ASC 280 can be found in the accompanying financial statements. The measure of segment assets is total assets as reported on the balance sheets. The Company has not generated any revenue as of the date of these financial statements. In accordance with ASU 2023-07, the Company discloses significant segment expenses that are regularly provided to the CODM and included in the reported measure of segment loss. For the years ended September 30, 2025 and 2024, significant segment expenses include the Company’s operating expenses classified as research & development and general & administrative on the accompanying statements of operations. These significant segment expenses are disaggregated by type in the following table (rounded to the nearest thousand):

 

 

 

Year Ended September 30,

 

 

 

 2025

 

 

 2024

 

Research and development:

 

 

 

 

 

 

Salaries, wages & employee benefits

 

$5,900,000

 

 

$6,050,000

 

Stock-based compensation

 

 

832,000

 

 

 

2,896,000

 

Depreciation and amortization expense

 

 

3,846,000

 

 

 

3,925,000

 

Clinical trial expense

 

 

615,000

 

 

 

315,000

 

Supplies & materials

 

 

2,267,000

 

 

 

2,098,000

 

Other operating expenses

 

 

2,427,000

 

 

 

2,877,000

 

General & administrative:

 

 

 

 

 

 

 

 

Salaries, wages & employee benefits

 

 

1,444,000

 

 

 

1,450,000

 

Stock-based compensation

 

 

1,078,000

 

 

 

1,374,000

 

Legal & accounting fees

 

 

1,054,000

 

 

 

616,000

 

Public & investor relation costs

 

 

2,863,000

 

 

 

2,209,000

 

Other operating expenses

 

 

2,484,000

 

 

 

2,542,000

 

Interest expense, net

 

 

649,000

 

 

 

746,000

 

Other income, net

 

 

(48,000)

 

 

(178,000)

Net loss

 

$25,411,000

 

 

$26,920,000

 

Historical Timeline

Fiscal YearFiled
2025Dec 29, 2025Showing above
2015Dec 11, 2015

About Segments Disclosures

Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.

Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.